Masimo Corporation
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Masimo Corporation is a global medical technology company specializing in the development and manufacture of innovative noninvasive patient monitoring technologies, medical devices, and a wide variety of sensors. Its core products include Masimo SET® pulse oximetry for arterial blood oxygen saturation and pulse rate monitoring; rainbow® Pulse CO-Oximetry for noninvasive blood constituent measurement; brain function electroencephalogram (EEG) monitoring; respiration rate, capnography, and anesthetic agent monitoring systems; and the Root™ patient monitoring and connectivity platform alongside the Patient SafetyNet™ remote patient surveillance system. The company serves hospitals, emergency medical services, physician offices, long-term care facilities, veterinarians, and consumers through direct sales, distributors, and OEM partners. Founded in 1989 and headquartered in Irvine, California, Masimo operates globally across the healthcare and consumer health markets. Recent significant developments include Masimo's divestiture of its consumer audio business, Sound United, which comprises premium audio brands such as Bowers & Wilkins®, Denon®, Polk Audio®, Marantz®, Definitive Technology®, Classé®, and Boston Acoustics®, sold to Harman International, a Samsung Electronics subsidiary, for approximately $350 million, completed in late 2025. This strategic move enables Masimo to focus more intensively on its core professional healthcare segment and enhance its innovation pipeline in medical technology. Additionally, Masimo expanded its hospital automation and remote patient monitoring capabilities through a partnership with Cleveland Clinic to improve hospital-based remote care. The company also launched the Stork™ Over-the-Counter baby monitoring system, which received FDA clearance, and the Masimo Opioid Halo™, the first and only FDA-authorized opioid overdose prevention and alert system. Masimo advanced its wearable health technology portfolio by introducing the Masimo W1™ watch in collaboration with Philips and expanded the HEOS® health tracking platform for enhanced consumer health monitoring connectivity. Despite facing a cybersecurity breach in 2025 that temporarily disrupted manufacturing operations, Masimo continues to demonstrate robust market penetration and innovation in noninvasive monitoring solutions worldwide. Masimo recently won a $634 million patent infringement verdict against Apple covering blood-oxygen reading technology, underscoring its leadership in medical technology intellectual property. Masimo maintains a diversified portfolio of products targeted to acute care, cardiac intensive care, neonatal ICU, home care, and emergency medical services, leveraging proprietary single-patient and reusable sensors and cables. Its healthcare solutions integrate noninvasive technologies to deliver vital patient information for optimized clinical decision-making. The company’s strategic focus remains on driving adoption of its advanced signal processing, biosensing, and photonics technologies to enhance patient care across multiple healthcare settings globally.
IART or MASI: Which Is the Better Value Stock Right Now?
Masimo Shareholders Approve Acquisition by Danaher
Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones
DXCM or MASI: Which Is the Better Value Stock Right Now?
Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study
Masimo Corporation $MASI Shares Bought by Cwm LLC
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Masimo Corporation $MASI
Apple Scores Key Win As Trade Commission Rejects Masimo's Bid To Reinstate Apple Watch Import Ban
Are MASI, CECO, MPX Obtaining Fair Deals for their Shareholders?
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
SG Americas Securities LLC Increases Stock Position in Masimo Corporation $MASI
Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
Harbor Health Care ETF Q4 2025 Portfolio Review
American Century Companies Inc. Boosts Position in Masimo Corporation $MASI
Bet on 5 Top-Ranked Stocks With Rising P/E
Halper Sadeh LLC is Investigating Whether KW and MASI are Obtaining Fair Deals for their Shareholders